PolyPid Virtual KOL Event to Discuss the Significant Unmet Medical Need in Surgical Site Infections and Company Update on the Progress of D-PLEX100 Phase 3 Trial
DATE: | June 17, 2024 |
---|---|
TIME: | 10:00 AM EDT |
LOCATION: | Virtual |
About The Event
Join PolyPid for a virtual Key Opinion Leader (KOL) event featuring Charles E. Edmiston, Ph.D. (Emeritus Professor of Surgery, Division of Vascular Surgery, Medical College of Wisconsin), who will discuss the significant clinical and economic burden, and current medical practice for the prevention of surgical site infections (SSIs).
The event will highlight PolyPid’s lead product candidate, D-PLEX100, and its ongoing Phase 3 SHIELD II trial evaluating D-PLEX100 for the prevention of abdominal colorectal SSIs.
A live question and answer session with Professor Edmiston and the company’s management will follow the formal presentation.